No lab values handed to you. No diagnosis in the chart. Rx Rounds hands you a medication list: the same way community pharmacy actually works. You reason your way to the diagnoses, the interactions, and the therapy problems hiding inside it.
Easy cases give you context. Hard cases give you a chief complaint and raw lab values; you calculate the rest, the way you would on the floor.
Interactions and therapy problems are drawn from a curated library validated against primary literature and current practice, including cases where the "textbook answer" has since been revised, or where new trial data changed what the correct answer even is.
The attending defends a correct answer even when you push back hard. Confidence isn't evidence, and the tool is built to know the difference.
Standard LLMs are good at conversation, not clinical precision. They can confuse a substrate for an inhibitor, miss a pharmacokinetic cascade, or fold the moment a student pushes back with confidence instead of evidence. Rx Rounds is built to keep those two things separate.
A growing set of verified clinical traps, interactions, and myth-correcting entries, checked against primary literature before they're ever used in a case.
Applies that verified library to new, unscripted patient cases in real time: free to reason and challenge you, never free to invent the clinical facts.
We don't generate a case and hope the pharmacology holds up. Each interaction, therapy problem, or diagnostic trap in Rx Rounds is checked against primary literature, FDA safety communications, and real-world adverse event data before it goes into the library, and it stays there only if it would actually change how a pharmacist manages the patient.
Some entries teach you to catch something real and dangerous. Others exist to correct something that sounds right but isn't; knowing what to unlearn matters as much as knowing what to catch. And when the evidence shifts, whether a trial gets reanalyzed, a guideline gets revised, or a black-box warning gets added, the library shifts with it.
Join the waitlist and be first in when it launches. Waitlist members get a discount on their first three months once premium access goes live.
First 3 months discounted for waitlist members